Roche launches new breast cancer drugs in India
Swiss drug major Roche has launched in India two new medicines for treating breast cancer claiming increased survival benefit and improved quality of life for patients.
Oct 12, 2015, 18:10 PM IST
Cipla-Novartis patent row: DIPP looking into merit of case
The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access.
Nov 02, 2014, 11:51 AM IST
Cipla asks govt to revoke Novartis' patent; launches its drug
Taking the patent battle to Novartis, India's Cipla has launched low-cost generic version of the Swiss drug maker's respiratory drug Indacaterol sold under the Onbrez brand, while asking the government to revoke patents over the medicine.
Oct 30, 2014, 19:02 PM IST
